HCA Healthcare, Inc. $HCA Stock Holdings Lessened by Mondrian Investment Partners LTD

Mondrian Investment Partners LTD trimmed its stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 99.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 1,389 shares of the company’s stock after selling 248,741 shares during the quarter. Mondrian Investment Partners LTD’s holdings in HCA Healthcare were worth $648,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. National Pension Service lifted its position in shares of HCA Healthcare by 2.9% in the third quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after purchasing an additional 17,531 shares in the last quarter. Savant Capital LLC raised its position in HCA Healthcare by 37.7% during the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock valued at $1,938,000 after acquiring an additional 1,246 shares in the last quarter. Nordea Investment Management AB raised its position in HCA Healthcare by 11.2% during the fourth quarter. Nordea Investment Management AB now owns 1,084,590 shares of the company’s stock valued at $507,393,000 after acquiring an additional 108,849 shares in the last quarter. Sector Gamma AS raised its position in HCA Healthcare by 36.0% during the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after acquiring an additional 2,883 shares in the last quarter. Finally, AlphaQuest LLC raised its position in HCA Healthcare by 2,855.2% during the third quarter. AlphaQuest LLC now owns 5,999 shares of the company’s stock valued at $2,557,000 after acquiring an additional 5,796 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently weighed in on HCA shares. Barclays cut their price objective on shares of HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Truist Financial reduced their target price on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a report on Monday, April 27th. TD Cowen lowered their price target on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, April 27th. Stephens reduced their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Finally, UBS Group boosted their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research note on Monday, February 23rd. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $515.77.

Read Our Latest Report on HCA

HCA Healthcare Trading Up 0.5%

Shares of HCA Healthcare stock opened at $394.40 on Friday. The firm has a fifty day simple moving average of $465.16 and a 200-day simple moving average of $483.61. The stock has a market capitalization of $87.49 billion, a price-to-earnings ratio of 13.56, a PEG ratio of 1.25 and a beta of 1.18. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company’s revenue was up 4.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

About HCA Healthcare

(Free Report)

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Further Reading

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.